
CAS 1922954-32-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
6-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione
CAS :Formule :C13H14BrN3O2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :324.17326-Bromo-8-cyclopentyl-2-hydroxy-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one (Palbociclib Impurity)
CAS :6-Bromo-8-cyclopentyl-2-hydroxy-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one (Palbociclib Impurity)Degré de pureté :98%Masse moléculaire :324.17g/mol6-Bromo-8-cyclopentyl-2-hydroxy-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one (Palbociclib Impurity)
CAS :Degré de pureté :97%Masse moléculaire :324.1786-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione
CAS :Produit contrôlé<p>Applications 6-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione is an impurity of Palbociclib (P139900), a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 which may be useful in the treatment of breast cancer.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009);<br></p>Formule :C13H14BrN3O2Couleur et forme :NeatMasse moléculaire :324.1736-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione
CAS :<p>6-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione is a compound with antiviral properties. It belongs to the class of tenofovir and has been shown to inhibit the replication of certain viruses. This compound also exhibits calpain inhibitory activity, which may have potential therapeutic applications in conditions related to calpain dysregulation. Additionally, 6-Bromo-8-cyclopentyl-5-methylquinazoline-2,7(3H,8H)-dione has been studied for its impurities and interactions with other compounds such as etoricoxib, blonanserin, 27-hydroxycholesterol, peptidoglycan, cellulose, oxysterols, proton pump inhibitors like omeprazole or esomeprazole, dopamine antagonists like haloperidol or risperidone and nonsteroidal anti</p>Formule :C13H14BrN3O2Degré de pureté :Min. 95%Masse moléculaire :324.17 g/mol





